This course has concluded on April 19, 2022

CE InformationCourse Outline

    Understanding and Protecting the Kidney: Identifying Patients at High Risk for Kidney Failure in the Cath Lab

    Faculty

    Shweta Bansal, MD, FASN
    Associate Clinical Professor of Medicine
    Division of Nephrology, Department of Medicine
    University of Texas Health at San Antonio
    San Antonio, Texas

    Anand Prasad, MD
    Associate Professor of Medicine
    Director of Cardiac Catherterization Laboratory
    University of Texas Health at San Antonio
    San Antonio, Texas

    provider statement

    Provided by North American Center for Continuing Medical Education, LLC, an HMP Company.

    For questions regarding this educational activity, please call 609-371-1137 or email info@naccme.com.

    Intended Learners

    This activity is designed for interventional cardiologists, nephrologists, vascular surgeons, interventional radiologists, cardiothoracic surgeons, clinical cardiologists, nurses, technicians and others involved in the treatment of patients with heart disease and kidney failure in the cardiac catheterization lab.

    Learning Objectives

    After completing this activity, participants should be able to:

    • Identify the connection between heart disease and kidney function.
    • Define what contrast-induced acute kidney injury is, what causes it, and the influence of comorbidities for patients in the cath lab. 
    • Describe the key recommendations and treatment options for these high-risk patients in the cath lab. 

    Claiming Credit

    To be eligible for credit, participants must complete the online activity, a post-test assessment, and the evaluation. Upon completing the activity, there will be instructions on how to print a certificate or other documentation of credit.

    Release Date: February 7, 2018
    Reviewed: April 19, 2021
    Expiration Date: April 19, 2022
    Estimated Time to Complete: 1.25 hours

    There is no fee associated with this activity.

    COMMERCIAL SUPPORT

    NACCME would like to thank the following company who has supported the "Understanding and Protecting the Kidney: Identifying Patients at High Risk for Kidney Failure in the Cath Lab" through educational grants and/or in-kind support: Osprey Medical

    Continuing education

      In support of improving patient care, NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Save

    PHYSICIANS

    NACCME designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™.

    Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Nurses

    This continuing nursing education activity awards 1.25 contact hour.

    Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.25 contact hour. 

    PHYSICIAN ASSISTANTS

    NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 credit. PAs should only claim credit commensurate with the extent of their participation.

    VASCULAR & INTERVENTIONAL RADIOGRAPHERS

    Understanding and Protecting the Kidney: Identifying Patients at High Risk for Kidney Failure in the Cath Lab taking place from February 28, 2020 to February 28, 2021 has been approved for 1.00 A+ ARRT CE credits by the Association for Vascular and Interventional Radiographers (AVIR). The AVIR is an ARRT Recognized Continuing Education Evaluating Mechanism, (RCEEM).

    USE OF PROPRIETARY NAMES

    This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.

    UNAPPROVED AND/OR INVESTIGATIONAL USES OF DRUGS AND DEVICES

    This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of NACCME.

    disclaimers

    The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.

    Neither NACCME nor any of its subsidiaries or affiliates is affiliated with, or formally endorsed by a medical society.

    The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME or HMP. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

    DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

    NACCME, LLC is an independent provider of continuing medical education. NACCME, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.

    In accordance with our disclosure policies, NACCME is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real conflicts of interest between any individual with control over the content and any ineligible company (commercial interest) as defined by the ACCME.

    Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:

    1. Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and;
    2. any investigational, off-label, or non-FDA approved content or discussion

    NACCME has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner.

    Education has been independently peer-reviewed to validate content, mitigate identified conflicts of interest, and ensure:

    1. All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
    2. All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.
    3. Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.

    FACULTY

    The faculty has reported the following:

    Dr. Bansal: Consultant—Osprey Medical

    Dr. Prasad: Advisory Board—Osprey Medical; Consultant—GE Medical

    CLINICAL REVIEWER

    Robert S. Dieter, MD, RVT, FACC
    Loyola University Medicine
    Chicago, Illinois

    Dr. Dieter has disclosed no relevant financial relationship with any ineligible company (commercial interest).

    PLANNING COMMITTEE

    Susie Seaman, NP, MSN, CWOCN (nurse planner)
    Susie Seaman Wound Care Consulting
    San Diego, CA

    Ms. Seaman has disclosed no relevant financial relationship with any ineligible company (commercial interest).

    NACCME planners and staff include Sam Conforti, Randy Robbin, Greaton Sellers, Margie Stefan, and Colleen Waters.

    No NACCME planner or staff has disclosed a relevant financial relationship with any ineligible company (commercial interest).

    ADA Statement

    North American Center for Continuing Medical Education (NACCME) complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.

    Privacy Policy

    NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint providers. NACCME and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

    Copyright © 2021 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.